Skip to main content

US ClosedU.S. Closed

ROIV: Roivant Sciences Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs.

52W Range

87thpctl

Volume

1.51×avg

Market Cap

25.07BUSD

P/E Ratio

-91.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Roivant Sciences Ltd.

ROIVNASDAQ Global Market·USD·Closed

Roivant Sciences Ltd.

ROIVNASDAQ·USD·Closed

$34.71

−7.64%

$34.71

−$2.87 (7.64%)

52W Range

87thpctl

Volume

1.51×avg

Mkt Cap

25.07BUSD

P/E

-91.3TTM

Div Yield

–ann